Injury Recovery
Overview
Acute and chronic injury recovery encompassing soft tissue damage, musculoskeletal injuries, and post-surgical healing. Peptide therapy accelerates natural repair processes by upregulating growth factors, improving angiogenesis, and reducing inflammation at the injury site.
Recommended Peptides
- BPC-157 – systemic and local healing via angiogenesis and nitric oxide pathways; the gold standard for injury recovery
- TB-500 – promotes actin upregulation and cell migration; excellent for systemic distribution to injury sites
- PEG-MGF – mechano growth factor variant; stimulates satellite cell activation for muscle repair
- GHK-Cu – copper peptide that remodels extracellular matrix and reduces scar tissue formation
- AOD-9604 – fat-derived growth hormone fragment with anti-inflammatory and regenerative properties
Protocols
Related Conditions
Research Summary
A 2025 systematic review of 36 BPC-157 studies confirmed consistent musculoskeletal healing enhancement (PMID-40756949). TB-500 increased re-epithelialization by 42-61% in wound models (PMID-10469335). BPC-157 and TB-500 combination (Wolverine Stack) provides complementary mechanisms: angiogenesis (BPC-157) + cell migration (TB-500). Ipamorelin is the first selective GH secretagogue with bone-protective properties (PMID-11735244). A Phase 2 RCT for BPC-157 in hamstring repair (NCT07437547, n=120) is currently recruiting.
Related
#condition #musculoskeletal